BIOIDENT Technologies Inc., the leading company in the development
of printed opto-electronic solutions for life sciences, today
announced that the company is a co-winner in the semiconductor
category for the seventh annual Wall Street Journal contest for
Technology Innovation. BIOIDENT was awarded for the development of its
PhotonicLab Platform(TM), which enables rapid in-vitro diagnostics,
chemical and biological threat detection, and environmental testing
without the need for off-site lab analysis.
"We are delighted to win this prestigious award that recognizes
our innovative work on the cutting edge of nanotechnology," said Dr.
Wasiq Bokhari, CEO for BIOIDENT. "Once again, BIOIDENT is being
acknowledged as the pioneer in applying its unique printed
opto-electronics to real-world applications. We will continue to
leverage our unique technology to develop new solutions to address
major industry challenges."
Utilizing the latest breakthroughs in science and nanotechnology,
the BIOIDENT PhotonicLab Platform is used to produce the world's first
disposable photonic lab-on-a-chip solution for next-generation mobile
analytics applications, such as water and food analysis, chemical and
biological agent detection, and point-of-care diagnostics. BIOIDENT
employs a process developed by its parent company, Austria's NANOIDENT
Technologies AG, for using an inkjet printer to print electronic
circuits on a variety of surfaces, such as plastic foil or glass; the
technology makes it possible to apply photosensitive semiconductors
directly onto a lab-on-a-chip. The Platform eliminates the need for
complex and expensive readout systems and delivers unprecedented
mobility and sensitivity based on existing biological and chemical
assays.
About The Wall Street Journal Technology Innovation Awards
As part of the 2007 award nomination process, The Wall Street
Journal screened more than 800 applications, narrowing the field to
about 150 entries. A panel of 13 judges picked category winners and
runners-up in 12 different entry categories including computing
systems, energy, environment, materials and other base technologies,
media/broadcasting, medical research, medical devices,
network/internet technologies, network security, semiconductors,
software and transport. Each entrant was required to offer extensive
details and explain why the entry merited consideration. Judging
criteria included innovativeness, clarity of explanation, whether the
innovation was covered by patents and if it had achieved some measure
of success. Factors the panel considered included: the innovation
should have gone well beyond what already existed and cannot simply
represent incremental improvements; it needed to address major
challenges for which new solutions would have a wide-ranging impact in
a particular industry; the written application needed to be supported
by rigorous data rather than unsubstantiated claims of potential.
About BIOIDENT Technologies Inc.
BIOIDENT is the leader in the development of rapid, multi-assay
and mobile analytical and diagnostic systems. BIOIDENT integrates
highly sensitive printed photodetectors and electronics with various
existing Lab-on-a-Chip (LOC) technologies including lateral flow,
microfluidics and microarrays. BIOIDENT's systems are designed for
applications in in-vitro diagnostics, chemical and biological threat
detection, and environmental testing. BIOIDENT's award-winning
Photonic Lab(TM) Technology Platform eliminates the need for complex
and expensive readout systems and delivers unprecedented mobility and
sensitivity based on existing biological and chemical assays. Benefits
for BIOIDENT's customers and partners include high mobility, rapid
testing, multiplexing and low cost of ownership.
BIOIDENT is a subsidiary of Austrian-based NANOIDENT Technologies
AG, the world leader in printed opto-electronics. The company is
privately held with headquarters in Menlo Park, California. BIOIDENT
leverages NANOIDENT's SEMICONDUCTOR 2.0(TM) Platform technology and
its high-speed manufacturing process, which uses liquid conductive and
semi-conductive materials to print electronic circuits on almost any
surface using an inkjet printer. NANOIDENT also has the world's only
dedicated organic fabrication facility with a production output of
40,000 sq.m per year. For more information about the company, please
visit www.bioident.com.
